GlassScriptPhysician profile
David Heath Stacey
NPI 1740245893
$8,291.95
in general payments reported to CMS, 2019-2025
9 companies · $346 in 2025
The $346 reported for 2025 was more than what a typical Plastic Surgery Within The Head and Neck provider received nationally (typical 2025 total: $300).
See the full distribution for Plastic Surgery Within the Head and Neck
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,769 · 2020: $889 · 2021: $821 · 2022: $786 · 2023: $286 · 2024: $397 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,012 · Education: $16.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,011.71 |
| Education | $16.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $3,947.33 | 2019-2022 | |
| Stryker Corporation | $2,441.22 | 2019-2021 | |
| Abbvie INC. | $927.74 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Ethicon US, LLC | $596.51 | 2019-2023 | Stratafix |
| Acell, INC. | $182.40 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $98.10 | 2019 | |
| Revance Therapeutics, INC. | $73.44 | 2024 | Daxxify |
| Daiichi Sankyo INC. | $13.87 | 2021 | |
| Galderma Laboratories, L.P. | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Stacey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.